Open AccessSafety of maximal cardiopulmonary exercise testing in individuals with sickle cell disease: a systematic review
Author(s) -
Kellsey N Smith,
Tracy Baynard,
Peter Fischbach,
Jane S. Hankins,
Lewis L. Hsu,
Peggy Murphy,
Kiri K. Ness,
Shlomit RadomAizik,
Amy Tang,
Robert I. Liem
Publication year - 2021
Publication title -
british journal of sports medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.329
H-Index - 171
eISSN - 1473-0480
pISSN - 0306-3674
DOI - 10.1136/bjsports-2021-104450
Subject(s) - medicine , adverse effect , vo2 max , population , physical therapy , medline , disease , heart rate , blood pressure , environmental health , political science , law
We evaluated the safety of maximal cardiopulmonary exercise testing (CPET) in individuals with sickle cell disease (SCD). Maximal CPET using gas exchange analysis is the gold standard for measuring cardiopulmonary fitness in the laboratory, yet its safety in the SCD population is unclear.